Characterizing the fusogenicity of SARS-CoV-2 variants via Spike protein-mediated membrane fusion assay. The 69th Annual Meeting of the Japanese Society for Virology, Nagasaki, Japan.

Nasser H, Suzuki R, Kishimoto M, Shimizu R, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Saito A, Sato K, Matsuno K, Fukuhara T, Ikeda T. Characterizing the fusogenicity of SARS-CoV-2 variants via Spike protein-mediated membrane fusion assay. The 69th Annual Meeting of the Japanese Society for Virology, Nagasaki, Japan. Nov 13-15, 2022.